Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.

Br J Cancer · 1977 · PMC2025283 · PMID 322689

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

More recently, a controlled study by Leukaemia Group B in the U.S.A. (Bekesi, Roboz and Holland, 1977) has claimed that neuraminidase-treated AML cells (with or without an extract of tubercle bacillus MER) given to patients receiving chemotherapy, has produced a highly significant prolongation of remis- 271 272 R.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.